Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

An2 Therapeutics Inc (ANTX)

An2 Therapeutics Inc (ANTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

An2 Therapeutics Inc 1800 EL CAMINO REAL SUITE D MENLO PARK CA 94027 USA

www.an2therapeutics.com Employees: 41 P: 650-331-9090

Description:

AN2 Therapeutics Inc. is a clinical-stage biopharmaceutical company. It focused on developing treatments for rare, chronic and serious infectious diseases with high unmet needs. AN2 Therapeutics Inc. is based in MENLO PARK, Calif.

Key Statistics

Overview:

Market Capitalization, $K 31,022
Enterprise Value, $K 15,372
Shares Outstanding, K 29,829
Annual Sales, $ 0 K
Annual Net Income, $ -64,730 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -14,440 K
EBIT, $ -71,180 K
EBITDA, $ -74,040 K
60-Month Beta -0.22
% of Insider Shareholders 20.79%
% of Institutional Shareholders 90.47%
Float, K 23,628
% Float 79.21%
Short Volume Ratio 0.32

Growth:

1-Year Return -93.17%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.48 on 08/13/24
Next Earnings Date 11/14/24
Earnings Per Share ttm -2.26
EPS Growth vs. Prev Qtr 14.29%
EPS Growth vs. Prev Year 40.74%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ANTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -54.72%
Return-on-Assets % -49.52%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.32
Book Value/Share 3.30
Interest Coverage -3.39
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar